The second part of the book deals with Parkinson's disease (PD).
Chapter 9, opening this part of the book, includes general characterization of PD, its causes, and approach es for treatment.
Chapter 10 deals with metabolic changes in PD and, particularly restoration of dopamine levels.
The third part of the book summarizes data related to Huntington's disease (HD). The single chapter 11 of this part consists of neuropathology, genetic, protein misfold ing and aggregation, and therapeutic approaches.
The fourth part of the book describes biochemical and pathophysiological peculiarities of amyotrophic lat eral sclerosis (ALS) (chapter 12).
The fifth part of the book discusses types of trans missible spongiform encephalopathies (TSE), their genetics, anomalies of protein molecules, and therapeutic approaches (chapter 13).
The sixth part (chapter 14) provides a general review of neurodegenerative diseases and discusses their bio chemical and pathophysiological properties.
Each chapter contains a basic bibliography related to book topics, and a subject index is found at the end of the book. This book will be useful for researchers in protein chemistry and biochemistry, molecular biologists and physicians, and teachers and students of medical schools and universities specialized in proteomics.
